Patents for A61P 33 - Antiparasitic agents (21,787)
12/2004
12/29/2004EP1334094B1 Cholesterol lowering benzo[b]thiophenes and benzo[d]isothiazoles
12/29/2004EP1124576B1 Method for preparing solid phase conjugate vaccines
12/29/2004CN1558899A Spirocyclic 3-phenyl-3-substituted 4-ketolactams and 4-ketolactones
12/29/2004CN1558719A Nicotinic acid-heterocyclyl-amides and analogous pyrimidine derivatives serving as pesticides
12/29/2004CN1557333A Chinese traditional medicine composition and its preparation and quality control method thereof
12/29/2004CN1557318A Continuous release medicine composition and its preparation method
12/29/2004CN1182143C Bis-(N,N'-bis-(2-haloethyl) amino) phosphoramidates as antitumor agents
12/29/2004CN1181818C Method for treating protozoal infections
12/28/2004US6835747 Ft-0554a substances and process for the preparation thereof
12/28/2004US6835731 Chemokine receptor binding heterocyclic compounds
12/28/2004US6835716 Bactericides, antiprotozoa agents
12/28/2004US6835372 Mixtures of di-(tri)peptides and drugs such as cyclosporin used as aerosols; drug delivery
12/28/2004CA2331297C Hygromycin a derivatives
12/23/2004WO2004111076A1 Triamide derivative and process for producing the same
12/23/2004WO2004111070A1 Avermectin b1 monosaccharide derivatives
12/23/2004WO2004110454A1 COMPOSITION FOR TREATMENT FOR OR PREVENTION OF DISEASE NECESSITATING ADMINISTRATION OF ADENOSINE A2a RECEPTOR AGONIST
12/23/2004WO2004110149A1 Use of isoindolinone derivatives as insecticides
12/23/2004WO2004089917A3 Process for resolving 2,4-diamino-3,6-dihydro-1,3,5-triazines, useful for the treatment of disorders associated with insulin resistance syndrome
12/23/2004WO2003101995A8 Camptothecins with a modified lactone ring
12/23/2004US20040259927 Compounds for treatment of sleep apnea, respiratory system disorders or kidney failure
12/23/2004US20040259879 Antiarthritic agents; colon cancer, neurodegenerative agents
12/23/2004US20040259864 Substituted pyrimidinone derivatives as ligands of integrin receptors
12/23/2004US20040259821 In nonaqueous solvent; therapy for blood disorders; anticancer agents
12/23/2004US20040259820 Kit for delivering decitabine in vivo
12/23/2004US20040258675 Novel mutated form of arginine deiminase
12/23/2004DE10325672A1 Pharmazeutisches Präparat zur Behandlung von parasitären Tropenkrankheiten A pharmaceutical preparation for the treatment of parasitic tropical diseases
12/22/2004EP1489082A1 Intermediate compounds
12/22/2004EP1488800A1 Agent for the treatment of protozoal diseases
12/22/2004EP1487852A1 Anti-protozoal vaccine
12/22/2004EP1487825A1 Process to obtain dibenzylbutyrolactonic lignans; process to obtain synthetic derivatives from lignanes bearing anti-chagas chemoprophylactic and therapeutical activities
12/22/2004EP1487494A2 Inhibition of inflammatory cytokine production by stimulation of brain muscarinic receptors
12/22/2004EP1487484A2 Use of mixtures of lipopeptides for vaccine production
12/22/2004EP1487477A2 Methods of using flt3-ligand in immunization protocols
12/22/2004EP1487432A2 Suramin and derivatives thereof as topical microbicide and contraceptive
12/22/2004CN1556856A Vaccines from infectious agents
12/22/2004CN1556808A Heterocyclic compound based on N6-substituted adenine, methods of their preparation, their use for preparation of drugs, cosmetic preparations and growth regulators, pharmaceutical preparations, cosme
12/22/2004CN1555808A Malaria fewer preventing medicinal composition
12/22/2004CN1181043C Quaternary bis-ammonium salt precursors and their uses as prodrugs having antiparasitic activity
12/21/2004US6833444 An erythromycin-type antibiotic based on a perhydro-oxazolo(5,4-c)oxacyclotetradecine ring; bactericides; antiprotazoa agents; non-polyene and ansa macrolide antibiotics
12/21/2004US6833365 Such as 5-propionyl-6-cyclopentylsulfanylmethyl doxycycline; for treating diarrhea in immunodeficient individuals
12/21/2004CA2140649C Hybrid oligonucleotide phosphorothioates
12/16/2004WO2004108940A2 Viral genome vectors
12/16/2004WO2004108907A1 Nerve cell obtained by electrically pulse-treating es cell
12/16/2004WO2004108695A1 Anti-leishmania agent
12/16/2004WO2004108145A1 Therapeutical composition containing dentritic cells and use thereof
12/16/2004US20040254350 Immunomodulatory protein for use in diagnosis, treatment, and prevention of immune system, neurological, developmental, muscle and cell proliferative disorders
12/16/2004US20040254240 Anti-cancer nitro- and thia-fatty acids
12/16/2004US20040254199 For plants, animals; nematocides
12/16/2004US20040254192 2,4,5-trisubstituded thiazolyl derivatives and their antiinflammatory activity
12/16/2004US20040254191 Antiinflammatory agents; autoimmune diseases; controlling tumor necrosis factor; immunosuppressants
12/16/2004US20040254125 Anthelmintic composition
12/16/2004US20040253683 Cryptopain compositions for prophylaxis, treatment, diagnosis and detection of cryptosporidium species
12/16/2004US20040253588 Cytochrome p450 monooxygenase for use in identifying modulators for treatment, diagnosis and prevention of autoimmune/inflammatory, cell proliferative, developmental, endocrine, eye, metabolic, gastrointestinal and liver disorders
12/16/2004US20040253276 Oil-in-water emulsion of a 1-carboxylate-6-arylsulfamoyl cyclohexene and synthetic and naturally occurring phospholipids; nitric oxide or cytokine prodution inhibitors; cardiovascular disorders, autoimmune dieseases, septic shock; improved stability during autoclave sterilization
12/16/2004US20040253245 Modulating an immune response by administering a modulator of Notch intracellular domain protease activity, including modulators of presenilin and presenilin-dependent gamma secretase activity; immunotherapy; treatment of Alzheimer's disease
12/16/2004US20040253208 Interleukin-1 muteins useful as vaccine adjuvants
12/16/2004CA2524910A1 Therapeutical composition containing dendritic cells and use thereof
12/15/2004EP1486496A1 Substituted 2-(2,6-Dioxopiperidin-3-YP)-Phthalimides and 1-Oxoisoindolines and method fo reducing TNF alpha levels
12/15/2004EP1485488A2 Recombinant negative strand virus rna expression systems and vaccines
12/15/2004EP1485393A2 9-dexo-9a-aza-9a-methyl-9a-homoerythromycin a derivatives
12/15/2004EP1485389A1 Antiparasitic artemisinin derivatives (endoperoxides)
12/15/2004EP1485125A1 Improvements in vaccination
12/15/2004EP1485089A1 Combination treatments for chemokine-mediated diseases
12/15/2004EP1485086A1 Azabicyclic, azatricyclic and azaspirocyclic derivatives of aminocyclohexane as nmda, 5ht3, and neuronal nicotinic receptor antagonists
12/15/2004EP1485083A2 Dexanabinol and dexanabinol analogs regulate inflammation related genes
12/15/2004EP1387840B1 3,5-diamino-1,2,4-triazoles as kinase inhibitors
12/15/2004EP1383515B1 Activation of natural killer cells by adenosine a3 receptor agonists
12/15/2004EP1357932B1 Crystal modification of a cyclic depsipeptide having improved strength
12/15/2004EP1226137B8 Phenyl- and pyridyl-tetrahydro-pyridines having tnf inhibiting activity
12/15/2004CN1555269A Exothermic formulations for the treatment of ectoparasites
12/15/2004CN1554336A Process for preparing water soluble arteannuin preparation
12/15/2004CN1179951C Optical antimer of Saikexiaozuo and its preparing process and usage
12/09/2004WO2004105772A1 Pharmaceutical preparation for treating tropical parasitic diseases containing diaminazen-diaceturate and/or pentamidine
12/09/2004WO2004105762A1 Medical use of diazabicyclononene derivatives as inhibitors of parasite aspartic proteases
12/09/2004WO2004105738A2 Use of tetrahydropyridine derivatives
12/09/2004WO2003097585A3 Amidoacetonitrile compounds
12/09/2004WO2003080582A3 Fredericamycin derivatives
12/09/2004US20040249161 Biphenyl-derivatives as p38-kinase inhibitors
12/09/2004US20040249153 For therapy of inflammation, rheumatoid arthritis, osteoarthritis, osteoporosis and tumors
12/09/2004US20040249132 Nuclear hormone receptor ligand binding domain
12/09/2004US20040249123 Nuclear receptor for use in identifying modulator for diagnosis, prevention and treatment of cell proliferative, blood, cardiovascular, skin, inflammatory, bone and nervous system disorders
12/09/2004US20040248965 Indolin-2-one derivatives as anticarcinogenic agents for treating angiogenesis, lymphangiogenesis, filariasis
12/09/2004US20040248765 Tumour targeting prodrugs activated by metallo matrixproteinases
12/09/2004US20040247643 A miniature coated tablet or covered rod implant; smaller size and larger payloads than immediate release tablets; veterinary medicine
12/09/2004US20040247634 Treatment of parasitic disease
12/08/2004EP1484064A1 Therapeutical composition containing dentritic cells and use thereof
12/08/2004EP1483374A2 Use of l-alpha-lysophosphatidycholine to obtain the differentiation of monocytes in mature dendritric cells in vivo
12/08/2004EP1482988A1 METHOD OF RADIO−LABELLING BIOMOLECULES
12/08/2004EP1482984A2 Surrogate antibodies and methods of preparation and use thereof
12/08/2004EP1482955A1 Prophylactic and therapeutic treatment of infectious and other diseases with immunoeffector compounds
12/08/2004EP1482926A2 Amino-methyl substituted tetracycline compounds
12/08/2004EP1482791A1 Antimicrobial therapeutic compositions and methods of use
12/08/2004EP1434886A4 Mid 241 receptor, a novel g-protein coupled receptor
12/08/2004EP1363898A4 Compounds useful as modulators of melanocortin receptors and pharmaceutical compositions comprising same
12/08/2004CN1553892A Novel compounds and compositions as cathepsin inhibitors
12/08/2004CN1552322A Pharmaceutical compositions of tizoxanide and nitazoxanide
12/08/2004CN1179046C Erythromycins and its preparation method, use and compositions
12/08/2004CN1178940C Selective antagonists of A28 adenosine receptors
12/08/2004CN1178694C Use of IL-12 and IFN-'alpha' for treatment of infectiong diseases
12/07/2004US6828462 Amines such as 3,3,5,5-Tetramethyl-1-vinylcyclohexanamine hydrochloride, used as N-methyl-D-aspartate (NMDA), serotonin and nicotinic acetylcholine receptor antagonists